Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

RNA-Seq to investigate the effect of small molecular compounds on the maturation capacity of monocyte-derived dendritic cells


ABSTRACT: Modulating beta-catenin signaling has attractive therapeutic potential in cancer immunotherapy. Various studies have found that beta-catenin can mediate immune evasion in cancer and promote anti-inflammatory features of antigen-presenting dendritic cells. Multiple small-molecule compounds that inhibit Wnt/beta-catenin signaling are currently in clinical development, but none have reached routine clinical use. Thus, new inhibitors of beta-catenin signaling are desirable. This dataset is the result of an investigation of the effect of small molecular compounds axitinib, ICG-001, nitazoxanide, orlistat, and XAV-939 on the maturation capacity of monocyte-derived dendritic cells (moDC). Treatment of immature moDC was done in combination with the beta-catenin activator 6-BIO. Immature moDCs were obtained by isolating monocytes from PBMC using magnetic beads, which were then differentiated into moDCs using GM-CSF and IL-4 for four days. Compounds were added during the maturation of the moDCs, which was done by adding LPS to the cell culture. After the maturation period of 24 hours, the mature moDCs were collected and processed for RNA sequencing.

INSTRUMENT(S): NextSeq 500

ORGANISM(S): Homo sapiens

SUBMITTER: Benjamin Gabriel 

PROVIDER: E-MTAB-10757 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2020-02-21 | E-MTAB-8330 | biostudies-arrayexpress
2021-03-27 | GSE169717 | GEO
2009-07-27 | GSE13369 | GEO
2014-06-01 | E-GEOD-47621 | biostudies-arrayexpress
2014-06-01 | GSE47621 | GEO
2015-05-08 | E-GEOD-52894 | biostudies-arrayexpress
2010-05-15 | E-GEOD-13369 | biostudies-arrayexpress
2020-01-07 | GSE143143 | GEO
2015-05-08 | GSE52894 | GEO
2009-03-04 | E-GEOD-13296 | biostudies-arrayexpress